Alberto Paderno
Alberto Paderno, co-founder of CareForMe, is a head and neck surgeon at Humanitas Research Hospital and a pioneer in clinical trial innovation. With extensive experience as a Principal Investigator in oncology trials and a PhD in Clinical Trials Innovation, Alberto combines expertise in medicine and artificial intelligence to drive patient-centered, hybrid research models that improve trial accessibility and efficiency.
Alberto has been central to steering the trial design of Trials Of Life’s first clinical trial for an ADHD dietary intervention; helping prioritise the trial design and primary and secondary outcome measure and ensuring the trial is both pragmatic and ethical.
His clinical and research activities focus on head and neck oncology, with particular emphasis on laryngeal and hypopharyngeal cancer, oral malignant and potentially malignant disease, and transoral laser microsurgery. He is involved in various international studies in fields ranging from translational research, biomarkers, oncology, head and neck surgery, and artificial intelligence.Alberto has authored or co-authored 78 papers in peer-reviewed journals as well as five book chapters. He has served as Section Editor of Current Opinion in Otolaryngology & Head and Neck Surgery for the Head and Neck Oncology issue, since 2021. He is a member of the Editorial Board of Acta Otorhinolaryngologica Italica and has been a topic Editor in Frontiers in Oncology, since 2020.
Andrea Thornton
Andrea Thornton is a producer and filmmaker; her last documentary ‘ATTENTION PLEASE’ was made in the hope of bringing about reform on how we treat and recognise ‘labelled’ children in the Western World. ‘ATTENTION PLEASE’ had its first screening at the Cannes Film Festival and went on to premier in the US, winning ‘Best Short Documentary - Mental Health’ at the A.C. Cinefest, before being released worldwide on Amazon Prime. It also screened on all Virgin Atlantic flights.
Andrea’s journey into this field was deeply personal. In search of answers for her own son, who exhibited signs of ADHD, she consulted numerous experts but found no definitive solution. By chance, she discovered Neuro-Developmental Therapist Bob Allen, whose work on treating Retained Primitive Reflexes led to transformative changes in her child. Witnessing such a profound impact, she felt compelled to use her filmmaking skills to raise awareness of this little-known but highly promising approach.
Andrea is thrilled to become a trustee with 'Trials of Life'. She is eager to work with likeminded, passionate people, intent on bringing about real change and real hope for all.
Paul Michael Peeters
Paul Michel Peeters is a dynamic entrepreneur with a rich background in translational research, public-private partnerships, and innovative health solutions. With over a decade of experience at the crossroads of science and business, Paul excels at driving forward-thinking projects that blend evidence-based approaches with emerging technologies.
In addition to his academic achievements—holding a PhD in Biomedical Sciences, an MBA, and a Master’s in Biomedical Engineering—Paul is actively involved in multiple entrepreneurial ventures. His work spans health innovation, patient-centered solutions, and cutting-edge approaches like energy-based medicine, reflecting his passion for exploring integrative methodologies that align science with holistic healing.
Paul’s career is defined by his ability to manage complex, multi-stakeholder initiatives while fostering collaboration between academia, industry, and regulatory bodies. He is also a strong advocate for sustainable scientific practices, promoting FAIR (Findable, Accessible, Interoperable, and Reusable) data management principles to advance transparency and accessibility in research.
Guided by a vision of creating impactful, future-focused health solutions, Paul continues to push the boundaries of innovation, combining his entrepreneurial spirit with a dedication to improving lives through science and collaboration.
Lily Tang
Lily Tang, co-founder of CareForMe, brings a personal and compassionate approach to healthcare innovation. Inspired by her experiences as a patient and witnessing the challenges of clinical trials, Lily is committed to making healthcare more patient-centered and accessible. She focuses on creating solutions that bridge gaps and bring preventive care, community-based services, and decentralised clinical trials to communities and patient’s homes, with a human touch.
CareForme.io provides a transformative solution by decentralizing clinical trials and moving visits into the community. They enable sponsors to extend their trials beyond conventional sites by partnering with local primary care providers who have established, trusted relationships with their patients. With a network of over 300 nurses they boost patient recruitment, retention, and engagement—particularly in underserved or geographically remote areas.
Tadd Cannelas Wilson
Tadd grew up in the vibrant city of Greenwich, London, where he developed a passion for sports before ultimately finding his calling in basketball. After reaching a championship level, his focus shifted to supporting teammates in their recovery from injuries, which led him to his Sports Science degree in Bedfordshire. Eventually, he transitioned into advisory roles.
With over a decade of experience in sports and exercise science, personal training, and physical therapy, Tadd is dedicated to implementing the leading evidence based integrative health solutions.
He collaborates with top health professionals, offering expert advice to help individuals improve their well-being. He is proud to support the Trials of Life community and subscribes fully to the ethos and values which he shares with it’s founders.
Tadd will be giving input to the clinical trials steering individuals with health and fitness questions as well as providing fitness information and programs for the site and the upcoming clinical trials.
Nina Fischer-Yargici
Nina is a registered Nutritional Therapist (DipION, mBANT, CHNC) with a deep passion for regeneration and the interconnectedness of soil health and human well-being.
Currently, she is a key contributor at the Cool Farm Alliance, a collaborative community focused on advancing regenerative and sustainable agriculture. The organization harnesses globally aligned, credible, and science-based metrics, tools, and resources to drive meaningful impact in the sector. Nina also holds a Permaculture Design Certificate and is actively transforming her own and local community gardens into thriving food forests.
Nina’s commitment to investigating the relationship between brain health and lifestyle/nutrition interventions is personal. With ADHD, ASD, depression, and Alzheimer’s affecting her family, she has witnessed firsthand the transformative potential of simple dietary changes. Through six years of clinical practice and personal studies within her close network, she has recognized the vital importance of addressing our state of being overfed yet undernourished to enhance brain function.
Nikhil Yadala
Nikhil has extensive expertise in developing and deploying AI and Machine Learning products. He previously worked as a Data & Applied Scientist at Microsoft Bing Search and as a research assistant at EPFL, focusing on distributed computing and genetics.
Nikhil is committed to accelerating longevity research through the Healome.one application, which he developed to advance these goals. Healome is based upon an advance SOTA blood aging clocks (for full body and organ specific aging ) on top of 1.5M blood test records via partnerships from diagnostic test centres, research labs across the USA, UK, and India.
Healome.one is already working with Careforme.io to analyse blood work for decentralised clinical trials and support their trial participants. Healome.one is being integrated for our first ADHD dietary clinical trial to give AI assistance to our participants and to record functional cognitive test scores and feedback.
Michael Whitworth (Co-Founder)
Innovation and Strategy Officer
Michael has been instrumental is increasing the value and effectiveness of a number of leading international Life Science and Healthcare companies. He has also been key in raising funds for projects such as CDISC international research standards and moving the needle towards greater acceptance of clinical data standards with many leading research and pharmaceutical firms. While also organically growing a Life Science consultancy practice..
Michael’s innovative thinking, team focussed delivery and rich portfolio of Life Science Industry experts has transformed Life Science organisations across the globe. He has been Instrumental in providing the infrastructure required to deliver successfully new medicinal products to the market, at speed, using design thinking techniques across both R&D and Commercial organisations..
Michael has taken on senior roles in Pharma e.g. VP Business Operations in R&D reporting to the CMO and Head of R&D. The outcome delivering several new product approvals with the FDA and EMA as well as the acquisition of the company.
Larry Callahan (Co-Founder)
Science Officer
Larry Callahan grew up on the South side of Chicago as the oldest of eight children. He obtained a Bachelor’s Degree in Chemistry from Roosevelt University and a Ph.D. in Chemistry from the University of Chicago. His thesis was on the mechanism of the B-Z DNA transition. Larry also synthesized non-hydrolysable analogs of Adenosine Phosphosulfate (APS), and Phospho-Adenosine Phosphosulfate (PAPS). These analogs led to the purification and cloning of enzymes involved in sulfation.
After obtaining his Ph.D. Larry worked at the Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER). He was the first to show that CD4 based therapies were unlikely to be effective as a treatment for HIV and worked out the mechanism of polyanionic substances inhibiting HIV. He also explained the role of electrostatic charge distribution within HIV’s gp120 V3 loop in controlling both the pathogenicity and infectivity of HIV.Larry returned to FDA in 2008 and was responsible for the development of the ISO 11238 standard one of five standards that are part of the ISO Identification of Medicinal Products (IDMP) effort. He was responsible for the development of Global Substance Registration in collaboration with NIH’s National Center for Advancing Translational Sciences (NCATS).
Larry is committed to improving global health through the organization of information to further modernize regulation, drug development and address shortages of medical products. Trials of Life is an effort he has cofounded with Paul Houston, the goal of Trials of Life is to determine regimens that are truly effective in improving the human condition throughout the world.
Mandy Elliott
With a background in cognitive development and a strong commitment to evidence-based interventions, Mandy brings valuable expertise to Trials of Life in the areas of neurocognitive assessment and training. Her work at Thefocusacademy focuses on understanding and enhancing cognitive function across various conditions, including ADHD, Dyslexia, and executive function disorders..
Having witnessed firsthand the impact of neurofeedback and structured cognitive training, Mandy is dedicated to advancing research that explores non-pharmaceutical interventions for cognitive and neurological health. Her experience working with diverse populations—including children, adults, and corporate professionals—brings an important perspective to Trials of Life’s mission of driving high-quality research and education in innovative approaches to mental and neurological well-being. Mandy has had incredible results from neurofeedback in training children and adults how to improve their own attention by awareness of beta and theta waves to optimise states of learning and attention. .
At Trials of Life, Mandy will contribute insights into cognitive training methodologies, real-world applications to track cognitive function improvements during our clinical trials, and neuro-feedback, and the role of executive function in overall health. Her passion for bridging the gap between research and practical implementation makes her a valuable member of our team.
Aziz Diop
Aziz DIOP is a highly accomplished software engineer and regulatory IT expert with over two decades in pharmaceutical and medical device regulation in Europe and beyond. As Head of European Telematics Projects at ANSM, France’s National Agency for the Safety of Medicines and Health Products, he played a pivotal role in aligning the agency’s information systems with evolving European and international regulatory frameworks.
Recognized for his expertise in regulatory data management, Aziz was an active member of multiple EMA and EU working groups, including the European Network Data Board (EUNDB) and ISO IDMP initiatives, helping to define international standards for medicinal product identification. His contributions extended to the International Council for Harmonisation (ICH), where he was appointed as the EU Regulatory Topic Leader for eCTD v4.0, ensuring seamless electronic submissions across regulatory agencies worldwide.
Beyond Europe, Aziz has influenced regulatory transformations on a global scale. As an IT consultant for the Saudi Food & Drug Authority, he implemented the eCTD system and developed the GCC Module 1 framework, a standardized electronic submission process now used across all Gulf countries.
More recently, Aziz has been at the forefront of exploring the intersection of big data and regulatory affairs. As a member of the joint HMA/EMA Task Force on Big Data, he has worked to address the emerging challenges posed by AI, real-world evidence, and advanced analytics in regulatory decision-making. His career is defined by an ability to anticipate and shape the future of regulatory technology, ensuring that agencies worldwide can harness digital innovation to enhance public health and safety.
Venessa Moffat
Venessa helps business owners to grow their companies in a digital world, by applying strategic vision, and innovative tactics.
Venessa focuses on innovative technology solutions for sustainable growth. She holds a BSc in Computer Science, a Post Grad Diploma in Business Administration, as well as an MBA from Essex University, where she specialised in agile IT architectures for maximum business value. She has successfully led strategy development and implementation programmes in multiple international organisations, as well as helping start-up and scale-up companies achieve their growth ambitions.
From a personal perspective, Venessa is very keen on fitness and wellness. She is a qualified personal trainer as well as a running coach, which has allowed her to help many people improve various health outcomes through nutrition and exercise.
Paul Houston (Co-Founder)
Cinical Research Officer
Paul has worked in clinical research, clinical study design and medical data standards for the last 15 years while at EMA (European Medicines Agency) and CDISC (Clinical Data Standards) and now for Trials of Life. In that time he has ran projects on creating data standards for medical research such as IDMP (Identification of Medicinal Products) and standards for therapeutic areas such as cancer and vaccines. Paul also led data standards integration programs on European Commission funded projects while publishing a number of articles in top scientific journals on medical research standards and open clinical research systems and data data sharing and anonymisation.
With Trials of Life Paul is now looking to leverage that work and the wealth of quality standards work to elevate the evidence base for alternative medicines and integrative health programs. Paul has ADHD, he is self diagnosed, and has ‘biohacked’ and managed his symptons since he was a psychology student at Aston University in Birmingham England where he graduated with a Joint honours BSc in Psychology and Management.
One of Paul’s focuses will be to look at implementing clinical trials and observational trials where people can choose a selection of complementary programs for their heatlh, diet, and exercise needs to combat health and mental challenges they may face. This is an area fast gaining ground, once more, in a time where preventative medicine and functional medicine approaches are coming to the foreground.